Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1979 3
1980 1
1981 2
1985 1
1987 2
1988 1
1989 3
1990 4
1991 3
1992 2
1993 3
1994 5
1996 2
1997 7
1998 2
1999 2
2000 10
2001 4
2002 7
2003 4
2004 7
2005 7
2006 12
2007 8
2008 12
2009 14
2010 11
2011 15
2012 8
2013 15
2014 22
2015 33
2016 44
2017 38
2018 29
2019 22
2020 13
2021 19
2022 21
2023 15
2024 11

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

384 results

Results by year

Filters applied: . Clear all
Page 1
Head and neck cancer.
Argiris A, Karamouzis MV, Raben D, Ferris RL. Argiris A, et al. Among authors: raben d. Lancet. 2008 May 17;371(9625):1695-709. doi: 10.1016/S0140-6736(08)60728-X. Lancet. 2008. PMID: 18486742 Free PMC article. Review.
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck.
Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, Jones CU, Sur R, Raben D, Jassem J, Ove R, Kies MS, Baselga J, Youssoufian H, Amellal N, Rowinsky EK, Ang KK. Bonner JA, et al. Among authors: raben d. N Engl J Med. 2006 Feb 9;354(6):567-78. doi: 10.1056/NEJMoa053422. N Engl J Med. 2006. PMID: 16467544 Free article. Clinical Trial.
Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy.
Huang Q, Li F, Liu X, Li W, Shi W, Liu FF, O'Sullivan B, He Z, Peng Y, Tan AC, Zhou L, Shen J, Han G, Wang XJ, Thorburn J, Thorburn A, Jimeno A, Raben D, Bedford JS, Li CY. Huang Q, et al. Among authors: raben d. Nat Med. 2011 Jul 3;17(7):860-6. doi: 10.1038/nm.2385. Nat Med. 2011. PMID: 21725296 Free PMC article.
Phosphorylation of DGK.
Barbernitz X, Raben DM. Barbernitz X, et al. Among authors: raben dm. Adv Biol Regul. 2023 May;88:100941. doi: 10.1016/j.jbior.2022.100941. Epub 2022 Dec 7. Adv Biol Regul. 2023. PMID: 36508895 Review.
A phase I/Ib trial and biological correlate analysis of neoadjuvant SBRT with single-dose durvalumab in HPV-unrelated locally advanced HNSCC.
Darragh LB, Knitz MM, Hu J, Clambey ET, Backus J, Dumit A, Samedi V, Bubak A, Greene C, Waxweiler T, Mehrotra S, Bhatia S, Gadwa J, Bickett T, Piper M, Fakhoury K, Liu A, Petit J, Bowles D, Thaker A, Atiyeh K, Goddard J, Hoyer R, Van Bokhoven A, Jordan K, Jimeno A, D'Alessandro A, Raben D, McDermott JD, Karam SD. Darragh LB, et al. Among authors: raben d. Nat Cancer. 2022 Nov;3(11):1300-1317. doi: 10.1038/s43018-022-00450-6. Epub 2022 Nov 25. Nat Cancer. 2022. PMID: 36434392 Free PMC article. Clinical Trial.
Outcomes with durvalumab by tumour PD-L1 expression in unresectable, stage III non-small-cell lung cancer in the PACIFIC trial.
Paz-Ares L, Spira A, Raben D, Planchard D, Cho BC, Özgüroğlu M, Daniel D, Villegas A, Vicente D, Hui R, Murakami S, Spigel D, Senan S, Langer CJ, Perez BA, Boothman AM, Broadhurst H, Wadsworth C, Dennis PA, Antonia SJ, Faivre-Finn C. Paz-Ares L, et al. Among authors: raben d. Ann Oncol. 2020 Jun;31(6):798-806. doi: 10.1016/j.annonc.2020.03.287. Epub 2020 Mar 21. Ann Oncol. 2020. PMID: 32209338 Free PMC article.
Elusive structure of mammalian DGKs.
Ma Q, Srinivasan L, Gabelli SB, Raben DM. Ma Q, et al. Among authors: raben dm. Adv Biol Regul. 2022 Jan;83:100847. doi: 10.1016/j.jbior.2021.100847. Epub 2021 Dec 2. Adv Biol Regul. 2022. PMID: 34922895 Free PMC article. Review.
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study.
Rodger AJ, Cambiano V, Bruun T, Vernazza P, Collins S, Degen O, Corbelli GM, Estrada V, Geretti AM, Beloukas A, Raben D, Coll P, Antinori A, Nwokolo N, Rieger A, Prins JM, Blaxhult A, Weber R, Van Eeden A, Brockmeyer NH, Clarke A, Del Romero Guerrero J, Raffi F, Bogner JR, Wandeler G, Gerstoft J, Gutiérrez F, Brinkman K, Kitchen M, Ostergaard L, Leon A, Ristola M, Jessen H, Stellbrink HJ, Phillips AN, Lundgren J; PARTNER Study Group. Rodger AJ, et al. Among authors: raben d. Lancet. 2019 Jun 15;393(10189):2428-2438. doi: 10.1016/S0140-6736(19)30418-0. Epub 2019 May 2. Lancet. 2019. PMID: 31056293 Free PMC article.
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival.
Bonner JA, Harari PM, Giralt J, Cohen RB, Jones CU, Sur RK, Raben D, Baselga J, Spencer SA, Zhu J, Youssoufian H, Rowinsky EK, Ang KK. Bonner JA, et al. Among authors: raben d. Lancet Oncol. 2010 Jan;11(1):21-8. doi: 10.1016/S1470-2045(09)70311-0. Epub 2009 Nov 10. Lancet Oncol. 2010. PMID: 19897418 Clinical Trial.
Phosphatidic acid and neurotransmission.
Raben DM, Barber CN. Raben DM, et al. Adv Biol Regul. 2017 Jan;63:15-21. doi: 10.1016/j.jbior.2016.09.004. Epub 2016 Sep 20. Adv Biol Regul. 2017. PMID: 27671966 Free PMC article. Review.
384 results